Clinical Trial Update: A Study of Iguratimod in Patients With Active Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating the use of iguratimod in patients with active rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Iguratimod (iguratimod)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED